Fate Therapeutics: Suffering The Fate Of A Depressed Cell Therapy Sector

I've had an up and down relationship with Fate Therapeutics (NASDAQ: FATE ), in particular calling out some rallies I did not feel were based on something substantial, but then feelingI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of investing in this space.Analy ...